Bacterial Survival Amidst an Immune Onslaught: The Contribution of the Leukotoxins

1. MenestrinaG, Dalla SerraM, ComaiM, CoraiolaM, VieroG, et al. (2003) Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS Lett 552: 54–60.

2. VandeneschF, NaimiT, EnrightMC, LinaG, NimmoGR, et al. (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9: 978–984.

3. TristanA, FerryT, DurandG, DauwalderO, BesM, et al. (2007) Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus. J Hosp Infect 65 Suppl 2: 105–109.

4. GilletY, IssartelB, VanhemsP, FournetJC, LinaG, et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753–759.

5. LinaG, PiemontY, Godail-GamotF, BesM, PeterMO, et al. (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29: 1128–1132.

6. NaimiTS, LeDellKH, Como-SabettiK, BorchardtSM, BoxrudDJ, et al. (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976–2984.

7. VoyichJM, OttoM, MathemaB, BraughtonKR, WhitneyAR, et al. (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194: 1761–1770.

8. DiepBA, ChanL, TattevinP, KajikawaO, MartinTR, et al. (2010) Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A 107: 5587–5592.

9. LipinskaU, HermansK, MeulemansL, DumitrescuO, BadiouC, et al. (2011) Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 6: e22864 doi:10.1371/journal.pone.0022864.

10. KobayashiSD, MalachowaN, WhitneyAR, BraughtonKR, GardnerDJ, et al. (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204: 937–941.

11. VenturaCL, MalachowaN, HammerCH, NardoneGA, RobinsonMA, et al. (2010) Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS ONE 5: e11634 doi:10.1371/journal.pone.0011634.

12. DumontAL, NygaardTK, WatkinsRL, SmithA, KozhayaL, et al. (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 79: 814–825.

13. MorinagaN, KaihouY, NodaM (2003) Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol Immunol 47: 81–90.

14. GravetA, ColinDA, KellerD, GirardotR, MonteilH, et al. (1998) Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett 436: 202–208.

15. AlonzoFIII, BensonMA, ChenJ, NovickRP, ShopsinB, et al. (2012) Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol 83: 423–435.

16. NilssonIM, HartfordO, FosterT, TarkowskiA (1999) Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 67: 1045–1049.

17. SupersacG, PiemontY, KubinaM, PrevostG, FosterTJ (1998) Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb Pathog 24: 241–251.

18. MalachowaN, WhitneyAR, KobayashiSD, SturdevantDE, KennedyAD, et al. (2011) Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE 6: e18617 doi:10.1371/journal.pone.0018617.

19. MenestrinaG, SerraMD, PrevostG (2001) Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family. Toxicon 39: 1661–1672.

20. KanekoJ, KamioY (2004) Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 68: 981–1003.

21. HolzingerD, GieldonL, MysoreV, NippeN, TaxmanDJ, et al. (2012) Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J Leukoc Biol 92(5): 1069–1081.

22. MeunierO, FalkenrodtA, MonteilH, ColinDA (1995) Application of flow cytometry in toxinology: pathophysiology of human polymorphonuclear leukocytes damaged by a pore-forming toxin from Staphylococcus aureus. Cytometry 21: 241–247.

23. PerretM, BadiouC, LinaG, BurbaudS, BenitoY, et al. (2012) Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cell Microbiol 14: 1019–1036.

24. GravesSF, KobayashiSD, BraughtonKR, WhitneyAR, SturdevantDE, et al. (2012) Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J Leukoc Biol 92: 361–374.

25. MalachowaN, KobayashiSD, BraughtonKR, WhitneyAR, ParnellMJ, et al. (2012) Staphylococcus aureus leukotoxin GH promotes inflammation. J Infect Dis 206: 1185–1193.

26. KonigB, PrevostG, PiemontY, KonigW (1995) Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 171: 607–613.

27. ColinDA, MonteilH (2003) Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect Immun 71: 3724–3729.

28. HenslerT, KollerM, PrevostG, PiemontY, KonigW (1994) GTP-binding proteins are involved in the modulated activity of human neutrophils treated with the Panton-Valentine leukocidin from Staphylococcus aureus. Infect Immun 62: 5281–5289.

29. YoongP, PierGB (2012) Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun 80: 2894–2904.

30. YoongP, PierGB (2010) Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci U S A 107: 2241–2246.

31. CravenRR, GaoX, AllenIC, GrisD, Bubeck WardenburgJ, et al. (2009) Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS ONE 4: e7446 doi:10.1371/journal.pone.0007446.

32. KebaierC, ChamberlandRR, AllenIC, GaoX, BrogliePM, et al. (2012) Staphylococcus aureus alpha-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J Infect Dis 205: 807–817.

33. LofflerB, HussainM, GrundmeierM, BruckM, HolzingerD, et al. (2010) Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6: e1000715 doi:10.1371/journal.ppat.1000715.

34. LaventieBJ, RademakerHJ, SalehM, de BoerE, JanssensR, et al. (2011) Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins. Proc Natl Acad Sci U S A 108: 16404–16409.

35. CheungGY, OttoM (2012) The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections. Expert Opin Ther Targets 16: 601–612.

36. BrownEL, DumitrescuO, ThomasD, BadiouC, KoersEM, et al. (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15: 156–164.